|
ADAM9 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.08300000004158E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.499110E-03 |
| Normal-vs-Stage2 |
6.277600E-03 |
| Normal-vs-Stage3 |
1.761190E-03 |
| Normal-vs-Stage4 |
3.460000E-02 |
| Stage1-vs-Stage2 |
3.294800E-01 |
| Stage1-vs-Stage3 |
1.508440E-01 |
| Stage1-vs-Stage4 |
1.749840E-01 |
| Stage2-vs-Stage3 |
7.964600E-01 |
| Stage2-vs-Stage4 |
5.567000E-01 |
| Stage3-vs-Stage4 |
7.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.07749999999729E-05 |
| Normal-vs-AfricanAmerican |
7.173800E-04 |
| Normal-vs-Asian |
7.698800E-01 |
| Caucasian-vs-AfricanAmerican |
8.804000E-01 |
| Caucasian-vs-Asian |
3.372600E-01 |
| AfricanAmerican-vs-Asian |
2.658600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.415690E-04 |
| Normal-vs-Female |
1.53091999999244E-05 |
| Male-vs-Female |
2.856200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.345930E-02 |
| Normal-vs-Extreme_Weight |
1.612380E-02 |
| Normal-vs-Obese |
3.049900E-04 |
| Normal-vs-Extreme_Obese |
3.049200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.822000E-01 |
| Normal_Weight-vs-Obese |
2.169000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.697000E-01 |
| Extreme_Weight-vs-Obese |
2.538400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.423200E-01 |
| Obese-vs-Extreme_Obese |
3.839200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.209600E-02 |
| Normal-vs-Age(41-60Yrs) |
6.59020000015609E-07 |
| Normal-vs-Age(61-80Yrs) |
3.478700E-03 |
| Normal-vs-Age(81-100Yrs) |
9.391700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.938600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.036600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.847200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.290000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.500400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.752400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.405900E-04 |
| Normal-VS-Type2 PRCC |
9.024200E-04 |
| Normal-VS-KIRP CIMP |
2.192300E-02 |
| Normal-VS-Unclassified PRCC |
3.424800E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.654800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.235500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.351600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.037030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.717000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.888570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.316290E-02 |
| Normal-vs-N1 |
3.056000E-03 |
| Normal-vs-N2 |
1.601640E-01 |
| N0-vs-N1 |
5.867800E-02 |
| N0-vs-N2 |
2.352400E-01 |
| N1-vs-N2 |
2.972800E-01 |
|
|
